UVB-irradiation regulates VLA-4-mediated melanoma cell adhesion to endothelial VCAM-1 under flow conditions

Molecular Carcinogenesis

Volumn 50, Issue 1, 2011, Pages 58-65

  Wang, Lei ^a,c   Shirure, Venktesh S ^b   Burdick, Monica M ^b   Wu, Shiyong ^a  

^a OHIO UNIVERSITY   (United States)

^b Ohio University   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

HUVEC; Melanoma; Tumor metastasis; UVB; VCAM 1; VLA 4

Indexed keywords

CD146 ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; CYTOFLUOROMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ULTRAVIOLET B RADIATION;

CELL ADHESION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTEGRIN ALPHA4BETA1; MELANOMA; ULTRAVIOLET RAYS; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 78650182530     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20696     Document Type: Article

References (27)

1. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-573.
2. Desgrosellier JS, Cheresh DA. Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer 2010; 10: 9-22.
3. Giavazzi R, Foppolo M, Dossi R, Remuzzi A. Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest 1993; 92: 3038-3044.
4. Liang S, Dong C. Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions. Am J Physiol Cell Physiol 2008; 295: C701-C707.
5. DiVietro JA, Brown DC, Sklar LA, Larson RS, Lawrence MB. Immobilized stromal cell-derived factor-1alpha triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion. J Immunol 2007; 178: 3903-3911.
6. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-314.
7. Klemke M, Weschenfelder T, Konstandin MH, Samstag Y. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers. J Cell Physiol 2007; 212: 368-374.
8. Martin-Padura I, Mortarini R, Lauri D, et al. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res 1991; 51: 2239-2241.
9. Chigaev A, Zwartz G, Graves SW, et al. Alpha4beta1 integrin affinity changes govern cell adhesion. J Biol Chem 2003; 278: 38174-38182.
10. Masumoto A, Hemler ME. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J Biol Chem 1993; 268: 228-234.
11. Saini A, Seller Z, Davies D, Marshall JF, Hart IR. Activation status and function of the VLA-4 (alpha4beta1) integrin expressed on human melanoma cell lines. Int J Cancer 1997; 73: 264-270.
12. Kitayama J, Tsuno N, Sunami E, Osada T, Muto T, Nagawa H. E-Selectin can mediate the arrest type of adhesion of colon cancer cells under physiological shear flow. Eur J Cancer 2000; 36: 121-127.
13. Zaidi MR, Day CP, Merlino G. From UVs to metastases: Modeling melanoma initiation and progression in the mouse. J Invest Dermatol 2008; 128: 2381-2391.
14. Noonan FP, Recio JA, Takayama H, et al. Neonatal sunburn and melanoma in mice. Nature 2001; 413: 271-272.
15. Burdick MM, Chu JT, Godar S, Sackstein R. HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem 2006; 281: 13899-13905.
16. Clements JM, Newham P, Shepherd M, et al. Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin. J Cell Sci 1994; 107: 2127-2135.
17. Jones DA, Smith CW, McIntire LV. Leucocyte adhesion under flow conditions: Principles important in tissue engineering. Biomaterials 1996; 17: 337-347.
18. Burdick MM, McCaffery JM, Kim YS, Bochner BS, Konstantopoulos K. Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol 2003; 284: C977-C987.
19. Barthel SR, Gavino JD, Descheny L, Dimitroff CJ. Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 2007; 11: 1473-1491.
20. Langley RR, Carlisle R, Ma L, Specian RD, Gerritsen ME, Granger DN. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma. Microcirculation 2001; 8: 335-345.
21. Chigaev A, Waller A, Zwartz GJ, Buranda T, Sklar LA. Regulation of cell adhesion by affinity and conformational unbending of alpha4beta1 integrin. J Immunol 2007; 178: 6828-6839.
22. Shamri R, Grabovsky V, Feigelson SW, Dwir O, Van Kooyk Y, Alon R. Chemokine stimulation of lymphocyte alpha 4 integrin avidity but not of leukocyte function-associated antigen-1 avidity to endothelial ligands under shear flow requires cholesterol membrane rafts. J Biol Chem 2002; 277: 40027-40035.
23. Lin X, Tan SM, Law SK, Torres J. Two types of transmembrane homomeric interactions in the integrin receptor family are evolutionarily conserved. Proteins 2006; 63: 16-23.
24. Parthasarathy K, Lin X, Tan SM, Law SK, Torres J. Transmembrane helices that form two opposite homodimeric interactions: An asparagine scan study of alphaM and beta2 integrins. Protein Sci 2008; 17: 930-938.
25. Schneider D, Engelman DM. Involvement of transmembrane domain interactions in signal transduction by alpha/beta integrins. J Biol Chem 2004; 279: 9840-9846.
26. Li R, Mitra N, Gratkowski H, et al. Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix associations. Science 2003; 300: 795-798.
27. Luo BH, Springer TA, Takagi J. A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol 2004; 2: e153.